Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 192

1.

Antiplatelet antibody-induced thrombocytopenia does not correlate with megakaryocyte abnormalities in murine immune thrombocytopenia.

Guo L, Kapur R, Aslam R, Hunt K, Hou Y, Zufferey A, Speck ER, Rondina MT, Lazarus AH, Ni H, Semple JW.

Scand J Immunol. 2018 Jul;88(1):e12678. doi: 10.1111/sji.12678.

2.

The spleen dictates platelet destruction, anti-platelet antibody production, and lymphocyte distribution patterns in a murine model of immune thrombocytopenia.

Aslam R, Kapur R, Segel GB, Guo L, Zufferey A, Ni H, Semple JW.

Exp Hematol. 2016 Oct;44(10):924-930.e1. doi: 10.1016/j.exphem.2016.07.004. Epub 2016 Jul 12.

PMID:
27417974
3.

Antibody binding to megakaryocytes in vivo in patients with immune thrombocytopenia.

Arnold DM, Nazi I, Toltl LJ, Ross C, Ivetic N, Smith JW, Liu Y, Kelton JG.

Eur J Haematol. 2015 Dec;95(6):532-7. doi: 10.1111/ejh.12528. Epub 2015 Mar 13.

4.

The pathogenesis of chronic immune thrombocytopenic purpura.

McMillan R.

Semin Hematol. 2007 Oct;44(4 Suppl 5):S3-S11. doi: 10.1053/j.seminhematol.2007.11.002. Review.

PMID:
18096470
5.

Novel Murine Model of Immune Thrombocytopaenia through Immunized CD41 Knockout Mice.

Li X, Wang SW, Feng Q, Hou Y, Lu N, Ma CH, Gao CJ, Hou M, Peng J.

Thromb Haemost. 2019 Mar;119(3):377-383. doi: 10.1055/s-0038-1677032. Epub 2019 Jan 10.

PMID:
30630213
6.

A murine model of severe immune thrombocytopenia is induced by antibody- and CD8+ T cell-mediated responses that are differentially sensitive to therapy.

Chow L, Aslam R, Speck ER, Kim M, Cridland N, Webster ML, Chen P, Sahib K, Ni H, Lazarus AH, Garvey MB, Freedman J, Semple JW.

Blood. 2010 Feb 11;115(6):1247-53. doi: 10.1182/blood-2009-09-244772. Epub 2009 Dec 10.

7.

Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro.

Iraqi M, Perdomo J, Yan F, Choi PY, Chong BH.

Haematologica. 2015 May;100(5):623-32. doi: 10.3324/haematol.2014.115634. Epub 2015 Feb 14.

8.

Epidemiology and pathophysiology of immune thrombocytopenic purpura.

Gernsheimer T.

Eur J Haematol Suppl. 2008 Feb;(69):3-8. doi: 10.1111/j.1600-0609.2007.00998.x. Review.

PMID:
18211567
9.

Intrinsically impaired platelet production in some patients with persistent or chronic immune thrombocytopenia.

Rivière É, Viallard JF, Guy A, Kilani B, Vieira-Dias J, Pons AC, Couffinhal T, Pellegrin JL, James C.

Br J Haematol. 2015 Aug;170(3):408-15. doi: 10.1111/bjh.13444. Epub 2015 Apr 14.

PMID:
25873418
10.

Megakaryocytes and platelets in immune thrombocytopenic purpura.

Wang ZY, Shen ZX.

Baillieres Clin Haematol. 1997 Feb;10(1):89-107. Review.

PMID:
9154317
11.

A megakaryocyte with no platelets: anti-platelet antibodies, apoptosis, and platelet production.

Perdomo J, Yan F, Chong BH.

Platelets. 2013;24(2):98-106. doi: 10.3109/09537104.2012.669508. Epub 2012 Jun 28. Review.

PMID:
22742725
12.

Megakaryocyte apoptosis in immune thrombocytopenia.

Vrbensky JR, Nazy I, Toltl LJ, Ross C, Ivetic N, Smith JW, Kelton JG, Arnold DM.

Platelets. 2018 Nov;29(7):729-732. doi: 10.1080/09537104.2018.1475637. Epub 2018 May 22.

PMID:
29787328
13.

Downregulation of hypoxia-inducible factor-1α contributes to impaired megakaryopoiesis in immune thrombocytopenia.

Qi J, You T, Pan T, Wang Q, Zhu L, Han Y.

Thromb Haemost. 2017 Oct 5;117(10):1875-1886. doi: 10.1160/TH17-03-0155. Epub 2017 Aug 3.

PMID:
28771276
14.

Mouse Models for Immune-Mediated Platelet Destruction or Immune Thrombocytopenia (ITP).

Neschadim A, Branch DR.

Curr Protoc Immunol. 2016 Apr 1;113:15.30.1-15.30.13. doi: 10.1002/0471142735.im1530s113.

PMID:
27038460
15.

Investigation of megakaryocyte apoptosis in children with acute and chronic idiopathic thrombocytopenic purpura.

Uçar C, Oren H, Irken G, Ateş H, Atabay B, Türker M, Vergin C, Yaprak I.

Eur J Haematol. 2003 Jun;70(6):347-52.

PMID:
12756015
16.

Platelet destruction in immune thrombocytopenia. Understanding the mechanisms.

Bakchoul T, Sachs UJ.

Hamostaseologie. 2016 Aug 3;36(3):187-94. doi: 10.5482/HAMO-14-09-0043. Epub 2015 May 18. Review.

PMID:
25982994
17.

Cyclic thrombocytopenia in a patient treated with cyclosporine for refractory idiopathic thrombocytopenic purpura.

Shirota T, Yamamoto H, Fujimoto H, Harada Y, Okada K, Uchida H, Roppongi H, Hayashi T.

Am J Hematol. 1997 Dec;56(4):272-6.

18.

The effects of panaxadiol saponins on megakaryocytic maturation and immune function in a mouse model of immune thrombocytopenia.

Lin X, Yin L, Gao R, Liu Q, Xu W, Jiang X, Chong BH.

Exp Hematol. 2015 May;43(5):364-373. doi: 10.1016/j.exphem.2014.12.008. Epub 2015 Jan 8.

PMID:
25578384
19.

Allogeneic platelet transfusions prevent murine T-cell-mediated immune thrombocytopenia.

Guo L, Yang L, Speck ER, Aslam R, Kim M, McKenzie CG, Lazarus AH, Ni H, Hou M, Freedman J, Semple JW.

Blood. 2014 Jan 16;123(3):422-7. doi: 10.1182/blood-2013-08-523308. Epub 2013 Nov 20.

20.

Bone marrow examination in patients with immune thrombocytopenia: is there anything different in older patients?

Gunduz E, Kivanc BK, Arik D, Isiksoy S, Bal C, Akay OM.

Eur J Haematol. 2014 Aug;93(2):157-60. doi: 10.1111/ejh.12320. Epub 2014 Apr 9.

PMID:
24660825

Supplemental Content

Support Center